• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过最小化包膜不稳定性来设计 HIV-1 疫苗。

HIV-1 vaccine design through minimizing envelope metastability.

机构信息

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Sci Adv. 2018 Nov 21;4(11):eaau6769. doi: 10.1126/sciadv.aau6769. eCollection 2018 Nov.

DOI:10.1126/sciadv.aau6769
PMID:30474059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6248932/
Abstract

Overcoming envelope metastability is crucial to trimer-based HIV-1 vaccine design. Here, we present a coherent vaccine strategy by minimizing metastability. For 10 strains across five clades, we demonstrate that the gp41 ectodomain (gp41) is the main source of envelope metastability by replacing wild-type gp41 with BG505 gp41 of the uncleaved prefusion-optimized (UFO) design. These gp41-swapped trimers can be produced in CHO cells with high yield and high purity. The crystal structure of a gp41-swapped trimer elucidates how a neutralization-resistant tier 3 virus evades antibody recognition of the V2 apex. UFO trimers of transmitted/founder viruses and UFO trimers containing a consensus-based ancestral gp41 suggest an evolutionary root of metastability. The gp41-stabilized trimers can be readily displayed on 24- and 60-meric nanoparticles, with incorporation of additional T cell help illustrated for a hyperstable 60-mer, I3-01. In mice and rabbits, these gp140 nanoparticles induced tier 2 neutralizing antibody responses more effectively than soluble trimers.

摘要

克服包膜的亚稳定性对于基于三聚体的 HIV-1 疫苗设计至关重要。在这里,我们通过最小化亚稳定性提出了一种连贯的疫苗策略。对于五个谱系中的 10 个株系,我们通过用未切割的前融合优化 (UFO) 设计的 BG505 gp41 取代野生型 gp41,证明 gp41 外域 (gp41) 是包膜亚稳定性的主要来源。这些 gp41 交换三聚体可以在 CHO 细胞中以高产率和高纯度生产。gp41 交换三聚体的晶体结构阐明了中和抗性第三层病毒如何逃避抗体对 V2 顶点的识别。传播/原始病毒的 UFO 三聚体和含有基于共识的祖先 gp41 的 UFO 三聚体表明亚稳定性的进化根源。gp41 稳定的三聚体可以很容易地在 24 聚体和 60 聚体纳米颗粒上展示,并且为超稳定的 60 聚体 I3-01 说明了加入额外的 T 细胞帮助。在小鼠和兔子中,这些 gp140 纳米颗粒比可溶性三聚体更有效地诱导了第二层中和抗体反应。

相似文献

1
HIV-1 vaccine design through minimizing envelope metastability.通过最小化包膜不稳定性来设计 HIV-1 疫苗。
Sci Adv. 2018 Nov 21;4(11):eaau6769. doi: 10.1126/sciadv.aau6769. eCollection 2018 Nov.
2
Stabilized diverse HIV-1 envelope trimers for vaccine design.用于疫苗设计的稳定多样化的 HIV-1 包膜三聚体。
Emerg Microbes Infect. 2020 Dec;9(1):775-786. doi: 10.1080/22221751.2020.1745093.
3
SOS and IP Modifications Predominantly Affect the Yield but Not Other Properties of SOSIP.664 HIV-1 Env Glycoprotein Trimers.SOS 和 IP 修饰主要影响 SOSIP.664 HIV-1 Env 糖蛋白三聚体的产量而非其他性质。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.01521-19.
4
Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles.第一代 gp41 稳定的 HIV-1 包膜三聚体和纳米颗粒诱导的中和抗体。
mBio. 2021 Jun 29;12(3):e0042921. doi: 10.1128/mBio.00429-21. Epub 2021 Jun 22.
5
Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.预融合HIV-1包膜三聚体与四级结构特异性抗体复合物的免疫原性
J Virol. 2015 Dec 30;90(6):2740-55. doi: 10.1128/JVI.02380-15.
6
Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies.CHO 细胞系产生的无切割依赖性 HIV-1 三聚体引发强烈的自体 Tier 2 中和抗体。
Front Immunol. 2018 May 24;9:1116. doi: 10.3389/fimmu.2018.01116. eCollection 2018.
7
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.小鼠对裂解的可溶性HIV-1包膜三聚体的抗体反应在特异性上受到高度限制。
J Virol. 2015 Oct;89(20):10383-98. doi: 10.1128/JVI.01653-15. Epub 2015 Aug 5.
8
Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers.基于11种Env三聚体的HIV-1包膜糖蛋白生产的糖基化基准图谱。
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02428-16. Print 2017 May 1.
9
Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.可溶性、未切割的HIV-1包膜三聚体的构象状态
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.00175-17. Print 2017 May 15.
10
Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.未切割与成熟人免疫缺陷病毒膜包膜糖蛋白三聚体的比较。
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00277-18. Print 2018 Jun 15.

引用本文的文献

1
Rational design of next-generation filovirus vaccines with glycoprotein stabilization, nanoparticle display, and glycan modification.通过糖蛋白稳定化、纳米颗粒展示和聚糖修饰对下一代丝状病毒疫苗进行合理设计。
bioRxiv. 2025 Mar 2:2025.03.02.641072. doi: 10.1101/2025.03.02.641072.
2
The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple Platforms.通过多种平台稳定的HIV-1 C亚型儿科包膜糖蛋白的设计与免疫原性
Vaccines (Basel). 2025 Jan 22;13(2):110. doi: 10.3390/vaccines13020110.
3
Structure-guided design of a prefusion GPC trimer induces neutralizing responses against LASV.

本文引用的文献

1
Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains.可溶性融合前封闭 DS-SOSIP.664-Env 三聚体的多种 HIV-1 株系。
Cell Rep. 2017 Dec 5;21(10):2992-3002. doi: 10.1016/j.celrep.2017.11.016.
2
cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate.cGMP 生产和 BG505 SOSIP.664 的分析,BG505 SOSIP.664 是一种高度糖基化的三聚体 HIV-1 包膜糖蛋白疫苗候选物。
Biotechnol Bioeng. 2018 Apr;115(4):885-899. doi: 10.1002/bit.26498. Epub 2017 Dec 11.
3
High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers.
前融合糖蛋白三聚体的结构导向设计诱导针对拉沙病毒的中和反应。
NPJ Vaccines. 2025 Feb 22;10(1):37. doi: 10.1038/s41541-025-01090-4.
4
Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus.人呼吸道合胞病毒和人偏肺病毒未切割前融合封闭三聚体疫苗的合理设计。
Nat Commun. 2024 Nov 16;15(1):9939. doi: 10.1038/s41467-024-54287-x.
5
FcRider: a recombinant Fc nanoparticle with endogenous adjuvant activities for hybrid immunization.FcRider:一种具有内源性佐剂活性的重组Fc纳米颗粒,用于混合免疫。
Antib Ther. 2024 Sep 6;7(4):295-306. doi: 10.1093/abt/tbae023. eCollection 2024 Oct.
6
Design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platforms.通过多种平台稳定的HIV-1 C亚型儿科包膜糖蛋白的设计与免疫原性
bioRxiv. 2024 Sep 19:2024.09.14.613016. doi: 10.1101/2024.09.14.613016.
7
Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising Antibodies.展示能引发2级中和抗体的HIV-1包膜糖蛋白的双组分纳米颗粒疫苗的研发
Vaccines (Basel). 2024 Sep 18;12(9):1063. doi: 10.3390/vaccines12091063.
8
A Single-Component Multilayered Self-Assembling Protein Nanoparticle Vaccine Based on Extracellular Domains of Matrix Protein 2 against Both Influenza A and B.一种基于基质蛋白2细胞外结构域的单组分多层自组装蛋白纳米颗粒疫苗,可同时预防甲型和乙型流感。
Vaccines (Basel). 2024 Aug 28;12(9):975. doi: 10.3390/vaccines12090975.
9
Self-Assembled Ferritin Nanoparticles for Delivery of Antigens and Development of Vaccines: From Structure and Property to Applications.自组装铁蛋白纳米颗粒用于抗原传递和疫苗开发:从结构和性质到应用。
Molecules. 2024 Sep 5;29(17):4221. doi: 10.3390/molecules29174221.
10
A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice.一种核苷修饰的 mRNA 疫苗形成狂犬病病毒样颗粒,可在小鼠中引发针对狂犬病病毒感染的强烈细胞和体液免疫应答。
Emerg Microbes Infect. 2024 Dec;13(1):2389115. doi: 10.1080/22221751.2024.2389115. Epub 2024 Aug 14.
高通量蛋白质工程改善了可溶性HIV-1包膜糖蛋白SOSIP三聚体的抗原性和稳定性。
J Virol. 2017 Oct 27;91(22). doi: 10.1128/JVI.00862-17. Print 2017 Nov 15.
4
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization.通过超稳定化提高天然样 HIV-1 包膜三聚体的免疫原性。
Cell Rep. 2017 Aug 22;20(8):1805-1817. doi: 10.1016/j.celrep.2017.07.077.
5
Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike.开放和封闭结构揭示了HIV-1包膜刺突中的变构和柔韧性。
Nature. 2017 Jul 20;547(7663):360-363. doi: 10.1038/nature23010. Epub 2017 Jul 12.
6
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.使用优化方法通过HIV包膜三聚体免疫在非人灵长类动物中引发强大的二级中和抗体反应。
Immunity. 2017 Jun 20;46(6):1073-1088.e6. doi: 10.1016/j.immuni.2017.05.007.
7
Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers.降低可溶性、类天然HIV-1包膜糖蛋白三聚体上V3区的抗原性和免疫原性。
J Virol. 2017 Jul 12;91(15). doi: 10.1128/JVI.00677-17. Print 2017 Aug 1.
8
Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach.排列有序的HIV C亚型包膜三聚体颗粒阵列引发具有独特V2帽结合方式的中和抗体。
Immunity. 2017 May 16;46(5):804-817.e7. doi: 10.1016/j.immuni.2017.04.021.
9
Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein.在螺旋-卷曲转变处进行甘氨酸取代有助于稳定的C亚型HIV包膜糖蛋白的结构测定。
Immunity. 2017 May 16;46(5):792-803.e3. doi: 10.1016/j.immuni.2017.04.014.
10
A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure.一种广泛中和抗体通过长的、刚性化的阴离子β-发夹结构靶向动态HIV包膜三聚体顶端。
Immunity. 2017 Apr 18;46(4):690-702. doi: 10.1016/j.immuni.2017.03.017.